Mercury Biopharmaceutical Corporation (TPEX:6932)

Mercury Biopharmaceutical Statistics

Total Valuation

TPEX:6932 has a market cap or net worth of TWD 2.75 billion. The enterprise value is 2.60 billion.

Market Cap	2.75B
Enterprise Value	2.60B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6932 has 421.85 million shares outstanding. The number of shares has decreased by -4.54% in one year.

Current Share Class	421.85M
Shares Outstanding	421.85M
Shares Change (YoY)	-4.54%
Shares Change (QoQ)	+2.73%
Owned by Insiders (%)	41.80%
Owned by Institutions (%)	0.04%
Float	221.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11,197.79
PB Ratio	10.92
P/TBV Ratio	11.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-36.87
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-43.74

Financial Position

The company has a current ratio of 9.21, with a Debt / Equity ratio of 0.19.

Current Ratio	9.21
Quick Ratio	8.81
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.79
Interest Coverage	-83.05

Financial Efficiency

Return on equity (ROE) is -24.50% and return on invested capital (ROIC) is -13.72%.

Return on Equity (ROE)	-24.50%
Return on Assets (ROA)	-13.11%
Return on Invested Capital (ROIC)	-13.72%
Return on Capital Employed (ROCE)	-24.80%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	16
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6932 has paid 63,000 in taxes.

Income Tax	63,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.96% in the last 52 weeks. The beta is -2.76, so TPEX:6932's price volatility has been lower than the market average.

Beta (5Y)	-2.76
52-Week Price Change	-57.96%
50-Day Moving Average	8.70
200-Day Moving Average	12.32
Relative Strength Index (RSI)	27.23
Average Volume (20 Days)	656,993

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6932 had revenue of TWD 246,000 and -70.59 million in losses. Loss per share was -0.17.

Revenue	246,000
Gross Profit	208,000
Operating Income	-73.00M
Pretax Income	-70.53M
Net Income	-70.59M
EBITDA	-63.16M
EBIT	-73.00M
Loss Per Share	-0.17

Balance Sheet

The company has 198.92 million in cash and 46.85 million in debt, giving a net cash position of 152.06 million or 0.36 per share.

Cash & Cash Equivalents	198.92M
Total Debt	46.85M
Net Cash	152.06M
Net Cash Per Share	0.36
Equity (Book Value)	252.34M
Book Value Per Share	0.59
Working Capital	185.96M

Cash Flow

In the last 12 months, operating cash flow was -52.34 million and capital expenditures -7.16 million, giving a free cash flow of -59.50 million.

Operating Cash Flow	-52.34M
Capital Expenditures	-7.16M
Free Cash Flow	-59.50M
FCF Per Share	-0.14

Margins

Gross Margin	84.55%
Operating Margin	-29,676.42%
Pretax Margin	-28,670.73%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6932 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.54%
Shareholder Yield	n/a
Earnings Yield	-2.56%
FCF Yield	-2.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3